Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 23657501)

1.

MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.

Mao X, Li H, Sano Y, Gaestel M, Mo Park J, Payne AS.

J Invest Dermatol. 2014 Jan;134(1):68-76. doi: 10.1038/jid.2013.224. Epub 2013 Jun 27.

2.

p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.

Mao X, Sano Y, Park JM, Payne AS.

J Biol Chem. 2011 Jan 14;286(2):1283-91. doi: 10.1074/jbc.M110.172874. Epub 2010 Nov 15.

3.

Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.

Saito M, Stahley SN, Caughman CY, Mao X, Tucker DK, Payne AS, Amagai M, Kowalczyk AP.

PLoS One. 2012;7(12):e50696. doi: 10.1371/journal.pone.0050696. Epub 2012 Dec 3.

4.

The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?

Spindler V, Endlich A, Hartlieb E, Vielmuth F, Schmidt E, Waschke J.

Am J Pathol. 2011 Oct;179(4):1905-16. doi: 10.1016/j.ajpath.2011.06.043. Epub 2011 Aug 22.

5.

A new light on an old disease: adhesion signaling in pemphigus vulgaris.

Galichet A, Borradori L, Müller EJ.

J Invest Dermatol. 2014 Jan;134(1):8-10. doi: 10.1038/jid.2013.439.

6.

Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.

Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA.

J Clin Invest. 2000 Dec;106(12):1467-79.

7.

Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.

Kawasaki H, Tsunoda K, Hata T, Ishii K, Yamada T, Amagai M.

J Invest Dermatol. 2006 Dec;126(12):2621-30. Epub 2006 Jul 13.

8.

Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.

Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA.

J Biol Chem. 2010 Feb 5;285(6):3695-704. doi: 10.1074/jbc.M109.081570. Epub 2009 Dec 10.

9.

Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.

Shu E, Yamamoto Y, Aoyama Y, Kitajima Y.

Arch Dermatol Res. 2007 Jun;299(3):165-7. Epub 2007 Apr 13.

PMID:
17431647
10.

IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.

Nishifuji K, Olivry T, Ishii K, Iwasaki T, Amagai M.

Vet Immunol Immunopathol. 2007 Jun 15;117(3-4):209-21. Epub 2007 Feb 16.

PMID:
17350107
11.

Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.

Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M.

J Immunol. 2003 Feb 15;170(4):2170-8.

12.

Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR.

J Clin Invest. 1999 Feb;103(4):461-8.

13.

Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.

Heupel WM, Zillikens D, Drenckhahn D, Waschke J.

J Immunol. 2008 Aug 1;181(3):1825-34.

14.

Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin.

Berkowitz P, Chua M, Liu Z, Diaz LA, Rubenstein DS.

Am J Pathol. 2008 Dec;173(6):1628-36. doi: 10.2353/ajpath.2008.080391. Epub 2008 Nov 6.

15.

Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.

Spindler V, Vielmuth F, Schmidt E, Rubenstein DS, Waschke J.

J Immunol. 2010 Dec 1;185(11):6831-8. doi: 10.4049/jimmunol.1002675. Epub 2010 Oct 29.

16.

Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity.

Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y.

J Biol Chem. 2007 Jun 15;282(24):17866-76. Epub 2007 Apr 11.

17.

Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.

Spindler V, Rötzer V, Dehner C, Kempf B, Gliem M, Radeva M, Hartlieb E, Harms GS, Schmidt E, Waschke J.

J Clin Invest. 2013 Feb;123(2):800-11. doi: 10.1172/JCI60139. Epub 2013 Jan 9.

18.

In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.

Ishii K, Amagai M.

Methods Mol Biol. 2013;961:219-25. doi: 10.1007/978-1-62703-227-8_13.

PMID:
23325646
19.

Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.

Shimizu A, Ishiko A, Ota T, Tsunoda K, Koyasu S, Amagai M, Nishikawa T.

Arch Dermatol Res. 2002 Oct;294(7):318-23. Epub 2002 Sep 5.

PMID:
12373337
20.

A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis.

Bektas M, Jolly PS, Berkowitz P, Amagai M, Rubenstein DS.

J Biol Chem. 2013 Mar 29;288(13):9447-56. doi: 10.1074/jbc.M112.438010. Epub 2013 Feb 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk